Incorporated

<!-- Name:DistributionId Value:8781711 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:4500 -->…

<!-- Name:DistributionId Value:8778875 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:4500 -->…

<!-- Name:DistributionId Value:8756592 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:4500 -->…

<!-- Name:DistributionId Value:8750351 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value: -->…

Complementary technologies to improve wellbore quality, reduce drilling risk HOUSTON--(BUSINESS WIRE)--Regulatory News: SLB (NYSE: SLB) today announced it has completed the acquisition of Gyrodata Incorporated, a global company…

Complementary technologies to improve wellbore quality, reduce drilling risk HOUSTON--(BUSINESS WIRE)--SLB (NYSE: SLB) today announced it has completed the acquisition of Gyrodata Incorporated, a global company specializing in gyroscopic…

<!-- Name:DistributionId Value:8742036 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:9500 -->…

PDUFA Target Action Date is February 28, 2023 Cytokinetics to Host Conference Call and Webcast on December 14, 2022 at 8:30 am Eastern Time SOUTH SAN FRANCISCO, Calif., Dec. 13, 2022 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated…

SOUTH SAN FRANCISCO, Calif., Dec. 09, 2022 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the U.S. Food & Drug Administration (FDA) posted briefing documents for the Cardiovascular and Renal…

Welcomes the Appointment of New Independent Outside Directors Releases Comprehensive Corporate Value Enhancement Plan Requests the New Outside Directors Examine 3D’s Plan and Develop Targets for Capital Efficiency, Operating Margin…